News
Researchers in the Ciulli group report a first study describing the idea of a macrocyclic PROTAC. The research was published in the prestigious chemistry journal Angewandte Chemie.
News
Researchers in the Ciulli group report a first study describing the idea of a macrocyclic PROTAC. The research was published in the prestigious chemistry journal Angewandte Chemie.
Press release
The University of Dundee’s Professor David Horn has received a prestigious award in recognition of his contribution to global efforts to overcome the disease known as African sleeping sickness.
Press release
A University of Dundee researcher has been presented with a prestigious science award from the British Federation of Women Graduates (BFWG)
Feature
Our researchers are finding new ways to approach the complex puzzle that is Parkinson’s disease, offering hope of breakthroughs in diagnosis and treatment
Press release
Researchers at the University of Dundee have made a discovery they believe has the potential to put the brakes on the ‘runaway train’ that is Parkinson’s disease.
News
David Gray has been promoted to Personal Chair. He takes the title of Professor of Translational Biology which is in recognition of his extensive work within the Drug Discovery Unit (DDU) and Wellcome Centre for Anti-Infectives Research (WCAIR).
Feature
Parkinson’s is the fastest growing neurological condition in the world and at present, there is no cure
News
On October 1st 1969 Philip Cohen became a postdoc in Edmond Fischer’s at the University of Washington, Seattle, USA and started his research on protein phosphorylation.
News
Hannah Tovell a PhD student in Dario Alessi lab working with Claire Crafter (AstraZeneca) and Alessio Ciulli and Andrea Testa in his lab have elaborated a compound termed SGK3-PROTAC1 that induces selective degradation of SGK3 protein kinase.
News
DEBRA is delighted to share that funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa (EB) has been agreed.
News
Two academic entrepreneurs from the division of Biological Chemistry and Drug Discovery have made the final of the Converge Challenge 2019.
News
School of Life Sciences researcher Professor David Horn will receive a £2.1 million Investigator Award from Wellcome to decode gene expression mechanisms in trypanosomes, pathogenic protozoa that cause a range of human and animal diseases.
News
Professor Angus Lamond has been appointed as the 2019-20 British Society for Proteomics Research (BSPR) Lecturer.
Feature
The Dundee Parkinson’s Campaign is undoubtedly ambitious, but the University has never shied away from a challenge, particularly when it comes to world-leading research
News
Dr Susan Wyllie, Head of the Mode of Action (MoA) group, has been promoted to tenure track Principal Investigator in the School.
News
The University of Dundee has announced a new partnership with Eisai, one of the world’s leading research-based pharmaceutical companies.
Press release
The University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson’s disease
News
Ian Kelsall and Jiazhen Zhang, two postdoc’s in Philip Cohen’s lab, have discovered the function of HOIL-1.
Press release
A University of Dundee scientist has been awarded £1.4 million from Cancer Research UK to develop research that could bring a ceasefire to cellular warfare taking place within our DNA that can cause blood cancers such as Leukaemia.
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).